Brighter signs an agreement in the UK for clinical research with insulin-treated diabetes patients
Brighter AB (Publ) (The Company) today announces that it has signed an agreement with the Northern Care Alliance NHS Foundation Trust. The NHS is the National Health Service in the United Kingdom and the agreement covers a funded-research study with Actiste® Diabetes Management as a Service (ADMS) in the city of Salford.
Brighter has received approval for the study from the West Midlands - Black Country Research Ethics Committee and HRA and Health and Care Research Wales (HCRW). The signing of the agreement is the next step forward for the project.
Research projects of this kind are important for Brighter in order to move forward in publicly claiming the benefits that Actiste brings to people with diabetes. The UK study is a high-level clinical-research project that the company hopes will confirm scientifically relevant insights about the many levels of benefits that Actiste can provide for the management of both type 1 and type 2 insulin-treated diabetes. The gathered research data will be shared with the diabetes scientific community, front-line care providers, patients, health-insurance companies, and partners.
”Brighter has already finalised one pilot project in Sweden and an analysis of the results has been published. This agreement is another great milestone for the company, as the data-generation process is one of the most important steps in building the body of clinical evidence for Actiste,” says Erik Lissner, interim CEO at Brighter AB.
Brighter is planning to continue conducting user-experience projects and clinical-research studies, and believes that the scientific community will continue to take an interest in testing how Actiste may address unmet needs in the management of diabetes.
For further information, please contact:
Investor Relations
[email protected]
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10 [email protected], www.eminova.se
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision of facilitating the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter’s quality management system is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on the Nasdaq First North Growth Market/BRIG.
About NCA
Northern Care Alliance NHS Foundation Trust was established on 1 October 2021 bringing together Salford Royal NHS Foundation Trust and The Pennine Acute Hospitals NHS Trust. NCA provides hospital and community healthcare services in Salford, Oldham, Bury and Rochdale. Our dedicated team of around 20,000 staff delivers high standards of care and experience excellence to over one million people across Greater Manchester and beyond.
More information about the NCA can be found at www.northerncarealliance.nhs.uk.
